“…Several sterane derivatives were demonstrated to target LXR-α and LXR-β activation 253 , 307 , 310 , 353 and/or LXRa/Lxra and LXRB/Lxrb upregulation, 330 , 332 , 354 , 355 , 356 , 357 resulting in induction of ABCA1 / Abca1 . Celastrol, 330 , 332 digoxin, 253 fucosterol, 308 certain gypenosides, 354 ouabain, 253 platycodin D, 355 saikosaponin A, 356 24-( S )-saringosterol, 307 24-( S )-stigmast-5-ene-3β,24-diol, 307 taxarasterol, 353 testosterone, 357 and TR1 310 increased ABCA1 / Abca1 mRNA 307 , 308 , 310 , 330 , 332 , 353 , 354 , 356 , 357 and/or ABCA1 protein content 310 , 253 , 353 , 354 , 355 , 357 leading to an enhanced efflux of cholesterol in vitro 253 , 308 , 330 , 332 and decreased intracellular cholesterol and/or phospholipid levels in vitro 330 , 332 , 354 , 356 , 357 and in vivo in mice. 253 The effect of fucosterol was comparable to that of the standard ABCA1 / Abca1 inducer TO901317.…”